Laboratory technician Ruth Rutledge packages cerebrospinal fluid of the three confirmed meningitis cases in Minn., to send to the Centers for Disease Control and Prevention in Atlanta for further testing, at the Minnesota Department of Health in St. Paul, Minn., on Tuesday, Oct. 9, 2012. (AP Photo/Hannah Foslien)
A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.
Ameridose is located in Westborough, Mass. The New England Compounding Center, which produced a steroid linked to the outbreak, is in Framingham. Both firms are run by Barry Cadden and Greg Conigliaro.
Ameridose provides sterile medication in prefilled oral syringes to about 3,000 hospitals nationwide. It opened its doors in 2006, eight years after NECC opened.
The Massachusetts Department of Public Health says Ameridose agreed to the shutdown until inspections by state regulators and the U.S. Food and Drug Administration are completed.
There is no recall of Ameridose products.
The outbreak has sickened 137 people in 10 states. Twelve have died.